Nir Barzilai
Researcher who has argued that Metformin is geroprotective and has discussed it on Peter Attia's podcast.
Build a pod of every appearance and mention of Nir Barzilai.
15 videos discussing or featuring Nir Barzilai. Save them to your own pod, ask any question across them, and connect it to Claude or ChatGPT.
Common Themes
Videos Mentioning Nir Barzilai

197 - The science of obesity & how to improve nutritional epidemiology | David Allison, Ph.D
Peter Attia MD
Mentioned by Peter Attia as an early listener of the podcast, being in league with David Allison.

175 - The biology of aging, rapamycin, and other interventions that target the aging process
Peter Attia MD
A researcher whose work on centenarians shows they get chronic diseases later in life, rather than living longer with them, suggesting a 'phase shift' in disease onset.

171- Longevity science: caloric restriction studies, aging biomarkers & possible longevity molecules
Peter Attia MD
A researcher known for his strong advocacy of Metformin's benefits, even for healthy individuals, which differs from Steve's more skeptical view.

Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects
Andrew Huberman
Likely the senior Principal Investigator (PI) on the TAME trial.

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Peter Attia MD
Director of the Institute for Aging Research at Albert Einstein College of Medicine, known for longevity gene projects and research into Metformin.

Health & Longevity: A Conversation with Peter Attia (Episode #328)
Sam Harris
Researcher at Albert Einstein College of Medicine studying centenarians and exceptional longevity.

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging
Peter Attia MD
Researcher who leads the TAME study, aiming to evaluate the benefits of Metformin in non-diabetics for aging-related diseases.

The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show
Tim Ferriss
A researcher at Einstein who has championed the TAME human clinical trial for Metformin.

#103 – Looking back on the first 99 episodes: Strong Convictions, Loosely Held
Peter Attia MD
An expert on aging and longevity, who was interviewed on the podcast and discussed the potential of Metformin.

#35 – Nir Barzilai, M.D.: How to tame aging
Peter Attia MD
Founding director of the Institute for Aging Research at Albert Einstein, leading the TAME trial and a significant expert in longevity genetics.

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?
Peter Attia MD
A world expert on Metformin and its benefits, especially concerning its impact on longevity in non-diabetic individuals, and involved in the TAME study.

Dr. Peter Attia, MD — Fasting, Metformin, Athletic Performance, and More | The Tim Ferriss Show
Tim Ferriss
One of the world's experts on Metformin, leading a large clinical trial to test if it's a longevity drug for non-diabetics.

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)
Peter Attia MD
Mentioned as a past podcast guest discussing aging.

300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more
Peter Attia MD
Researcher who has argued that Metformin is geroprotective and has discussed it on Peter Attia's podcast.

204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D.
Peter Attia MD
Guest on the podcast, a physician and expert in longevity research, discussing his studies on centenarians and interventions like metformin.